维普中文期刊产品整合服务
38篇 您的检索式:作者名="SCARABIN PY"
    题名 作者 年代 出处 被引量
1Five frequent polymorphisms of plasminogen activator inhibitor 1 gene: lack of association between genotypes, PAI activity and triglyceride levels in a healthy population显示文摘Henry M Chomiki N Scarabin PY 1997Arteriscleosis1997,17,3:1
2Thrombose veineuse profonde:pidemiologie,facteurs de risque acquis Incidence and acquired risk factors for thrombophlebitis显示文摘Oger E Lacut K Scarabin PY 0,,:1
3Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk显示文摘Scarabin PY Oger E Plu-Bureau G 2003Lancet2003,362,9382:1
4Associations of fibrino- gen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction: the PRIME Study: Prospective Epidemiological Study of Myocardi- al Infarction 显示文摘Scarabin PY Aillaud MF Amouyel P 1998Thromb Haemost1998,80,5:1
5Progestogens and venous thromboembolism among postmenopausal women using hormone therapy显示文摘Canonico M Plu-Bureau G Scarabin PY 2011Maturitas2011,70,4:1
6Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction:the ECTIM显示文摘 Bara 1 Ricard S 1993Study arterioscler Thromb1993,13,:1
7Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives显示文摘 Vissac AM Kizin JM 1998Thromb Haemost1998,82,:1
8The 4G/SG genetic polymorphism in the promotor of the Plasminogen Activator Inhibitor I( PAI- l ) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infaction in the ECTIM study 显示文摘Ye S Green FR Scarabin PY 1995Thrombosis and Haemestasis1995,74,3:1
9Five frequent polymophisms of the PAI-1 gane:lack of association between genotypes,PAI activity,and triglyceride levels in healthy population显示文摘Henry M Chomiki N Scarabin PY 1997Arterioscler Thromb Vase Biol1997,17,5:1
10Differential association of o- ral and transdermal oestrogen-replacement therapy with venous throm- boembolism risk 显示文摘Scarabin PY Oger E Plu-Bureau G 2003Lancet2003,362,9382:1
11Association between TAFI antigen and Ala 147Thr polymorphism of the TAFI gene and the angina pectoris incidence-The PRIME Sdudy显示文摘MORANGE PE JUHAN-VAGUE I SCARABIN PY 2003Throm Haemost2003,89,:1
12Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk显示文摘Scarabin PY Oger E Plu-Bureau G 2003Lancet2003,362,9382:1
13Progestogens and venous thromboembolism among postmenopausal women using hormone therapy 显示文摘Canonico M Plu-Bureau G Scarabin PY 2011Maturitas2011,70,4:1
14Factor Ⅶ Arg/Gln353 polymorphism determines factor Ⅶ coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study显示文摘Lane A Green F Scarabin PY 1996Atherosclerosis1996,119,1:1
15Genctic bariation at the betafibrinogen locua in relation to plasma fibrinogen concentrations and resk of myocardian infarction显示文摘Scarabin PY Bara L Ricards 1993The ECTIM study Arterioscler Thromb1993,13,:1
16Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women显示文摘Olie V Canonico M Scarabin PY 2010Curr Opin Hematol2010,17,5:1
17Five frequent poly-morphisms of the PAI-1 gene : lack of association between geno-types, PAI activity, and triglyceride levels in a healthy population 显示文摘Henry M Chomiki N Scarabin PY 1997Arterioscler Thromb Vasc Biol1997,17,:1
18Progestogens and venous thromboembolism among postmenopausal women using hormone therapy 显示文摘Canonico M Plu - Bureau G Scarabin PY 2011Maturitas2011,70,4:1
19Factor Ⅶ Arg/Gln^353 polymorphism determines factor Ⅶ coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study 显示文摘Lane A Green F Scarabin PY 1996Atherosclerosis1996,119,1:1
20FactorⅦArg/Gln353 polymorphism determines factor eoagu/ant activity in patients with myocardial infarction(MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study 显示文摘Lane A Green F Scarabin PY 1996Atherosclerosis1996,119,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费